News | Radiology Business | August 10, 2023

Groups continue work to protect access to care as they protect patients from surprise medical bills 

Groups continue work to protect access to care as they protect patients from surprise medical bills

Getty Images


August 10, 2023 — The American College of Radiology (ACR), American College of Emergency Physicians (ACEP) and American Society of Anesthesiologists (ASA) applaud the Aug. 3 U.S. District Court for the Eastern District of Texas’ ruling that the government's exorbitant 600% fee increase to access the independent dispute resolution (IDR) process and its overly restrictive “batching” limitations violate federal law. The ruling does not impact the patient protections included in the No Surprises Act, which ACR, ACEP and ASA advocated for and continue to support, nor does it raise patient out-of-pocket costs. 

The court agreed with plaintiffs — the Texas Medical Association (TMA), the Texas Radiological Society and Houston Radiology Associated — that the government wrongly raised the fees to participate in the IDR process established to resolve out-of-network care billing disputes, and restricted providers’ ability to submit claims for similar services in “batches” without giving providers advance notice and an opportunity to comment. 

ACR, ACEP and ASA filed a joint amicus brief with the Texas court showing how fee guidance published Dec. 23 by the Centers for Medicare and Medicaid Services (CMS) is unworkable. Effective Jan. 1, 2023, CMS increased the non-refundable administrative fee to contest disputed insurer reimbursement from $50 to $350. This drastic increase precludes many providers — particularly radiologists — from participating as their billed services are routinely less than $350. 

In addition, interim final rules (IFR) published in October 2021 unreasonably limit the batching of claims for the IDR process to the same or similar service codes. This means that only claims for the same code billed to the same insurance plan within a 30-day period may be batched, further limiting IDR access. 

Physicians, who are forced to utilize the IDR process because of unreasonable insurance payments, are prevailing in the arbitrators’ decisions more than 70% of the time. The court’s ruling is an important step in ensuring that the dispute resolution system is accessible and fair, as envisioned by the law’s authors. 

Notably, the government has suspended the IDR process, effective immediately, because of this latest court decision. CMS termed this as an “Unplanned Outage.” Physicians now must await further government guidance on how to submit claims under the IDR process for reimbursement of services. 

ACR, ACEP and ASA stand ready to work with the federal government, patient groups and other stakeholders to find solutions that ensure a fair IDR process for out-of-network care payment that is sufficiently accessible, can ease growing case backlogs and will help safeguard patient access to care.  

The Texas case solely impacts the IDR process to determine provider payment for out-of-network care. 

For more information: www.acr.org 

 

Related CMS Content: 

ASTRO Issues Statement on MPFS Proposed Rule   

National Cancer Plan Details Goals and Strategies of Cancer Moonshot Program, Highlights Role of Imaging in Screening and Detection    

US Government Issues Final Rules for Surprise Billing    

CMS Withdraws Guidance on Surprise Billing, Out-of-Network Payment Disputes     

ACR Joins "No Surprises Act" Lawsuit to Protect Patient Care     

Major Medical Associations Ask Federal Court for Summary Judgement in No Surprises Lawsuit     

Radiation Oncologists Applaud Biden-Harris Administration's Renewed Commitment to Cancer Moonshot       

Racial/Ethnic Disparities Persist in Lung Cancer Screening Eligibility       

Primary Lung Cancers Detected by LDCT are at Lower Risk of Brain Metastases       

Physician and Patient Groups Call On CMS to Update Medicare Lung Cancer Screening Coverage       

USPSTF Expands Lung Cancer Screening Eligibility Thresholds        

Low-dose CT for Lung Cancer Screening: Benefit Outweighs Potential Harm       

Physician and Patient Groups Call On CMS to Update Medicare Lung Cancer Screening Coverage  


Related Content

News | Radiology Business

May 29, 2024 — Strategic Radiology added a third California member to the nation’s leading coalition of independent ...

Time May 29, 2024
arrow
News | Radiology Education

May 24, 2024 — The American Society of Radiologic Technologists (ASRT) has announced that its ASRT Foundation has ...

Time May 24, 2024
arrow
News | Enterprise Imaging

May 24, 2024 — International medical imaging IT and cybersecurity company Sectra’s enterprise imaging solution has been ...

Time May 24, 2024
arrow
News | Lung Imaging

May 24, 2024 — Smokers who have small abnormalities on their CT scans that grow over time have a greater likelihood of ...

Time May 24, 2024
arrow
News | Artificial Intelligence

May 23, 2024 — NewVue.ai, born from the radiology technology pioneers behind peerVue and recognized as a trailblazer in ...

Time May 23, 2024
arrow
News | Radiation Therapy

May 23, 2024 — RaySearch Laboratories AB and C-RAD announced a collaboration agreement, aiming at jointly developing ...

Time May 23, 2024
arrow
News | FDA

May 22, 2024 — The U.S. Food and Drug Administration (FDA) has issued a recall of the Hologic Inc. BioZorb marker due to ...

Time May 22, 2024
arrow
News | Artificial Intelligence

May 22, 2024 — Lunit, a provider of Artificial intelligence (AI)-powered solutions for cancer diagnostics and ...

Time May 22, 2024
arrow
News | Artificial Intelligence

May 21, 2024 — According to a newly-published study of nearly 5,000 screening mammograms interpreted by an FDA-approved ...

Time May 21, 2024
arrow
News | Point-of-Care Ultrasound (POCUS)

May 20, 2024 — Exo (pronounced “echo”), a medical imaging software and devices company, announced the release of Exo ...

Time May 20, 2024
arrow
Subscribe Now